(Q61853050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

arterial hypertension

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

A Wick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

N Schäfer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

N Dörner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

D Schemmer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Bendszus

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

W Wick

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

29 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

157-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19727565%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-009-0003-5

6 February 2020

exact match

0 references

cites work

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Hypertension as a surrogate marker for the activity of anti-VEGF agents

1 reference

12 December 2020

Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma

1 reference

12 December 2020

Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma.

1 reference

12 December 2020

Salvage therapy with single agent bevacizumab for recurrent glioblastoma.

1 reference

12 December 2020